Literature DB >> 26409920

Comparison Between Intraoperative Two-Space Injection Thoracic Paravertebral Block and Wound Infiltration as a Component of Multimodal Analgesia for Postoperative Pain Management After Video-Assisted Thoracoscopic Lobectomy: A Randomized Controlled Trial.

Xuezheng Zhang1, Luowa Shu2, Chaoxi Lin3, Pei Yang2, Ying Zhou4, Quanguang Wang2, Yiquan Wu2, Xuzhong Xu2, Xu Cui5, Xiaoming Lin3, Lielie Jin6, Tianzuo Li5.   

Abstract

OBJECTIVE: To compare paravertebral block under thoracoscopy with wound infiltration at an early stage after video-assisted thoracic lobectomy surgery.
DESIGN: A prospective, randomized, triple-blinded, placebo-controlled trial.
SETTING: A single-center university hospital. PARTICIPANTS: Patients scheduled for video-assisted thoracic lobectomy surgery between February 20, 2014 and June 1, 2014 randomly were allocated into paravertebral block (PVB) (n = 35) and infiltration (n = 35) groups.
INTERVENTIONS: In the PVB group, 0.5% ropivacaine was injected into the paravertebral space by the surgeon under direct vision with placebo infiltration of saline in the wounds. In the infiltration group, the wounds were infiltrated with 0.5% ropivacaine by the surgeon with a placebo paravertebral block. Subsequently, patient-controlled intravenous morphine analgesia and paracoxib were administered.
MEASUREMENTS AND MAIN RESULTS: The primary endpoints were visual analog scale (VAS) pain scores at rest and on cough 0, 2, 6, and 24 hours after surgery. The secondary endpoints were the total morphine during postoperative 0 hours to 24 hours, adverse events, and patient satisfaction with the analgesia. Sixty-one patients completed the study. VAS score on cough at each time point was significantly lower (p<0.05) and median (25th, 75th) morphine consumption was lower in the PVB group than in the infiltration group (26 [10, 35] mg and 42 [29, 58] mg, p<0.001, respectively). There was no difference in VAS score at rest. Patients in the PVB group had higher satisfaction with analgesia than in the infiltration group (p = 0.003).
CONCLUSIONS: As part of the multimodal postoperative analgesia, intraoperative paravertebral block provided better dynamic pain relief and reduced morphine consumption compared with local wound infiltration.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  nerve block/methods; pain; paravertebral block; postoperative; thoracic surgery; video-assisted

Mesh:

Substances:

Year:  2015        PMID: 26409920     DOI: 10.1053/j.jvca.2015.06.013

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Analgesic management after thoracoscopic surgery: recent studies and our experience.

Authors:  Hiroaki Kuroda; Yukinori Sakao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  One-stage Approach for Hybrid Atrial Fibrillation Treatment.

Authors:  Vincent Umbrain; Christian Verborgh; Gian-Battista Chierchia; Carlo de Asmundis; Pedro Brugada; Mark La Meir
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

3.  PROSPECT guidelines for video-assisted thoracoscopic surgery: a systematic review and procedure-specific postoperative pain management recommendations.

Authors:  S Feray; J Lubach; G P Joshi; F Bonnet; M Van de Velde
Journal:  Anaesthesia       Date:  2021-11-05       Impact factor: 12.893

4.  Effect of patient-controlled intravenous analgesia combined with flurbiprofen axetil and dezocine on postoperative analgesia for lobectomy (EPIC-FAD): a trial protocol.

Authors:  Jian Zhou; Qiang Pu; Lin Lin; Weelic Chong; Boran Chen; Yang Hai; Fei Liu; Lunxu Liu
Journal:  Trials       Date:  2021-03-01       Impact factor: 2.279

5.  Efficacy of Intrathoracic Intercostal Nerve Block on Postoperative Acute and Chronic Pains of Patients Undergoing Video-Assisted Thoracoscopic Surgery.

Authors:  Xiaoning Zhao; Xiaoqian Li; Ying Wang; Weijie Xiao; Baihui Zhang; Xin Meng; Xijia Sun
Journal:  J Pain Res       Date:  2022-08-06       Impact factor: 2.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.